LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q3 2025 13F Holders as of 30 Sep 2025

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
255,139,258
Share change
-1,196,786
Total reported value
$344,428,817
Put/Call ratio
11%
Price per share
$1.35
Number of holders
121
Value change
-$1,111,792
Number of buys
44
Number of sells
58

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q3 2025

As of 30 Sep 2025, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 255,139,258 shares. The largest 10 holders included Artal Group S.A., Siren, L.L.C., FMR LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock, Inc., Sessa Capital IM, L.P., CITADEL ADVISORS LLC, CIBC Private Wealth Group LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 121 institutional shareholders reporting positions in this security for the Q3 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.